Structured evidence table for Arabinoxylan Gut Microbiome Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Arabinoxylan Gut Microbiome Randomized Trial | Higher tryptophan levels promoted tyrosine degradation I and pectin degradation I metabolic modules; lower tryptophan levels were associated with glutamate degradation I, fructose degradation, and valine degradation modules. | 4 | Huang JK (2024) | Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis. |
| Arabinoxylan Gut Microbiome Randomized Trial | Microbiota tryptophan metabolism and the biosynthesis of indole derivatives play an important role in homeostasis and pathogenesis in the human body and can be affected by the gut microbiota. | 4 | Huang JK (2024) | Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis. |
| Arabinoxylan Gut Microbiome Randomized Trial | However, studies on the interplay between gut microbiota and tryptophan metabolites in patients undergoing dialysis are lacking. | 4 | Huang JK (2024) | Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis. |
| Arabinoxylan Gut Microbiome Randomized Trial | The results revealed that alpha and beta diversity were not associated with the experimental phase, interventional period, RBAC dosage, or time. | 4 | Schupfer E (2023) | Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound. |
| Arabinoxylan Gut Microbiome Randomized Trial | Explanatory factors, including diet and lifestyle, were significantly associated with alpha ( p p p < 0.05) during the interventional period. | 4 | Schupfer E (2023) | Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound. |
| Arabinoxylan Gut Microbiome Randomized Trial | In conclusion, the gut microbiome is highly individualised and modulated by RBAC as a dietary supplement, dependent on lifestyle and dietary intake. | 4 | Schupfer E (2023) | Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound. |
| Arabinoxylan Gut Microbiome Randomized Trial | This study investigated the effects of a modified rice bran arabinoxylan compound (RBAC) as a dietary supplement on the gut microbiota of healthy adults. | 4 | Schupfer E (2023) | Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound. |
Source documents